Skip to main content

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.

Publication ,  Journal Article
Alpert, MD; Harvey, JD; Lauer, WA; Reeves, RK; Piatak, M; Carville, A; Mansfield, KG; Lifson, JD; Li, W; Desrosiers, RC; Johnson, RP; Evans, DT
Published in: PLoS Pathog
2012

Live-attenuated strains of simian immunodeficiency virus (SIV) routinely confer apparent sterilizing immunity against pathogenic SIV challenge in rhesus macaques. Understanding the mechanisms of protection by live-attenuated SIV may provide important insights into the immune responses needed for protection against HIV-1. Here we investigated the development of antibodies that are functional against neutralization-resistant SIV challenge strains, and tested the hypothesis that these antibodies are associated with protection. In the absence of detectable neutralizing antibodies, Env-specific antibody-dependent cell-mediated cytotoxicity (ADCC) emerged by three weeks after inoculation with SIVΔnef, increased progressively over time, and was proportional to SIVΔnef replication. Persistent infection with SIVΔnef elicited significantly higher ADCC titers than immunization with a non-persistent SIV strain that is limited to a single cycle of infection. ADCC titers were higher against viruses matched to the vaccine strain in Env, but were measurable against viruses expressing heterologous Env proteins. In two separate experiments, which took advantage of either the strain-specificity or the time-dependent maturation of immunity to overcome complete protection against SIV(mac)251 challenge, measures of ADCC activity were higher among the SIVΔnef-inoculated macaques that remained uninfected than among those that became infected. These observations show that features of the antibody response elicited by SIVΔnef are consistent with hallmarks of protection by live-attenuated SIV, and reveal an association between Env-specific antibodies that direct ADCC and apparent sterilizing protection by SIVΔnef.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

2012

Volume

8

Issue

8

Start / End Page

e1002890

Location

United States

Related Subject Headings

  • Virology
  • Vaccines, Attenuated
  • Time Factors
  • Simian immunodeficiency virus
  • Simian Immunodeficiency Virus
  • Simian Acquired Immunodeficiency Syndrome
  • SAIDS Vaccines
  • Macaca mulatta
  • Immunity, Humoral
  • Antibody-Dependent Cell Cytotoxicity
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alpert, M. D., Harvey, J. D., Lauer, W. A., Reeves, R. K., Piatak, M., Carville, A., … Evans, D. T. (2012). ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog, 8(8), e1002890. https://doi.org/10.1371/journal.ppat.1002890
Alpert, Michael D., Jackson D. Harvey, W Anderson Lauer, R Keith Reeves, Michael Piatak, Angela Carville, Keith G. Mansfield, et al. “ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.PLoS Pathog 8, no. 8 (2012): e1002890. https://doi.org/10.1371/journal.ppat.1002890.
Alpert MD, Harvey JD, Lauer WA, Reeves RK, Piatak M, Carville A, et al. ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog. 2012;8(8):e1002890.
Alpert, Michael D., et al. “ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.PLoS Pathog, vol. 8, no. 8, 2012, p. e1002890. Pubmed, doi:10.1371/journal.ppat.1002890.
Alpert MD, Harvey JD, Lauer WA, Reeves RK, Piatak M, Carville A, Mansfield KG, Lifson JD, Li W, Desrosiers RC, Johnson RP, Evans DT. ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge. PLoS Pathog. 2012;8(8):e1002890.

Published In

PLoS Pathog

DOI

EISSN

1553-7374

Publication Date

2012

Volume

8

Issue

8

Start / End Page

e1002890

Location

United States

Related Subject Headings

  • Virology
  • Vaccines, Attenuated
  • Time Factors
  • Simian immunodeficiency virus
  • Simian Immunodeficiency Virus
  • Simian Acquired Immunodeficiency Syndrome
  • SAIDS Vaccines
  • Macaca mulatta
  • Immunity, Humoral
  • Antibody-Dependent Cell Cytotoxicity